BMSD : 10.65048
BMSD : 10.65048
https://doi.org/10.65048/ijbmr
Search
About Us
Authors
Reviewers
Editorial Board
Contact Us

International Journal of Biological and Medical Research (IJBMR)

Original Article
Year : 2026  |  Volume : 17  |  Issue : 2  |  Page : 8463-8468 Full Version
Evaluating the awareness of routine blood investigations and its impact on the clinical outcomes among patients with diabetes mellitus – a cross-sectional study
Int J Biol Med Res. 2026; 17(2): 8463-8468  |  DOI: 10.65048/ijbmr.2026.17.2.8463.1025
Sujatha Mahadevarao Premnath ¹, Saravana², Sivaa Rajendran³
¹Sujatha Mahadevarao Premnath, MD DNB , Associate Professor, Department of Biochemistry, Pondicherry Institute of Medical Sciences, Pondicherry
²Mr Saravana, Final Year MBBS student, Pondicherry Institute of Medical Sciences
³Sivaa Rajendran, MD, Professor, Department of Biochemistry, Vinayaka Mission Medical College and Hospital, Karaikal
Correspondence Address :
Dr. Sujatha Mahdaverao Premnath,
Associate Professor, Department of Biochemistry,
Pondicherry Institute of Medical Sciences (PIMS)
Pondicherry - 605014 E-mail: drsuj85@gmail.com
Received: January 21, 2026 Accepted: March 5, 2026 Published: April 5, 2026

Abstract
Background: Diabetes mellitus is a chronic metabolic disorder that requires regular biochemical monitoring to ensure effective glycemic control and prevent complications. Despite advances in diagnostic and therapeutic modalities, inadequate patient awareness regarding routine investigations remains a challenge. This study aimed to assess the level of awareness about routine laboratory investigations among diabetic patients and their association with glycemic control and complications.
Methods: A cross-sectional study was conducted among 205 diabetic patients attending a tertiary care hospital. Data on socio-demographic characteristics, type and duration of diabetes, treatment modalities, and awareness about laboratory investigations were collected using a structured questionnaire. Glycemic parameters (FBS, PPBS, and HbA1c) and complication prevalence were analysed. Statistical significance was assessed using chi-square, t-tests, and correlation analysis.
Results: Of the participants, 54.1% demonstrated good awareness and 45.9% poor awareness. Participants with good awareness had significantly better fasting glucose (158.7 ± 9.5 mg/dL vs. 162.2 ± 10.7 mg/dL; p = 0.013) and HbA1c levels (6.9 ± 2.13% vs. 7.5 ± 2.08%; p = 0.043). Awareness was significantly associated with age, education, duration of diabetes, and frequency of clinic visits. A negative but significant correlation was observed between awareness and FBS and HbA1c (r =-0.42, -0.39 and p value 0.001, 0.002, respectively)
Conclusion: Higher awareness of laboratory investigations is associated with improved glycemic control, particularly in fasting glucose and HbA1c levels. However, awareness alone did not significantly reduce complication rates, suggesting the need for sustained educational interventions, regular follow-up, and behavioural reinforcement. Strengthening structured patient education programs can enhance self-management and reduce the long-term burden of diabetes.
Keywords
Diabetes Mellitus, Lab investigations, Knowledge, Awareness

Introduction

Diabetes Mellitus (DM) is one of the leading causes of morbidity and mortality worldwide, with an alarming increase in prevalence.  Currently, nearly 537 million people worldwide are affected by diabetes.[1] According to the International Diabetes Federation (IDF) Atlas 2021, India ranks among the top countries with 77 million people with DM and 25 million with prediabetes.[2]  More than 50% of people are unaware of their diabetic status, which leads to health complications if not detected and treated early.[3]

Effective management of requires a multifaceted approach that includes lifestyle modifications, pharmacological interventions, and regular monitoring through laboratory investigations. Laboratory investigations play a cornerstone role in the management of diabetes. Both routine and investigation to screen complications are indispensable and should be conducted at regular intervals for screening, deciding on the therapeutic regimen, monitoring the response, and looking for complications.[4]

Building foundational knowledge about routine tests lays the groundwork for comprehending the broader context of diabetes management, better communication between patients and healthcare providers, and improved quality of life for diabetic patients. Awareness of blood test results helps patients and healthcare providers make informed decisions about adjusting medication dosages or treatment plans to maintain optimal blood sugar control. From an Indian survey, it was found that an important barrierto diabetic management is the lack of awareness among the people affected.[5] Also, many studies from India have proved that diabetics lack proper knowledge about the long-term complications.[6] These gaps in awareness can lead to poor glycemic control, delayed diagnosis of complications and higher health care costs. Evaluating the level of awareness among diabetic patients about routine blood investigations provides valuable information on the existing educational gaps and barriers to optimal care. Furthermore, comparing glycemic control and the prevalence of long-term complications between patients with good awareness and those with poor awareness can help determine whether awareness helps in creating better clinical outcomes.

In this context, the present study aimed to assess the awareness of routine blood investigations among individuals with diabetes mellitus, and to determine if the level of awareness has any influence on their glycemic control and the presence of complications

Materials and Method

This is an observational, cross-sectional study conducted in a tertiary care hospital in South India from April 2025 to September 2025. The participants for the study were recruited from the General Medicine outpatient department, whocame for diabetic care and routine investigations. Both male and female patients of the age group between 18-75 years who have been diagnosed with DM for at least 1 year were included in the study.Pregnant mothers with gestational diabetes, Patients with significant cognitive impairment, newly diagnosed diabetes mellitus, pregnant mothers, severe comorbidities, malignancy, anaemia, hemoglobinopathies, other associated causes of chronic diseases other than diabetes, malignancy, etc. were excluded. The sample size was calculated using the formula

Where n is the required sample size for each group and Zα/2 and Zβ are critical values from the standard normal distribution (Z distribution) that correspond to the desired significance level and power of the test, respectively. Assuming the level of significance α as 0.05 and power (1-β) 0.80 or 80%, Δ the smallest difference between the two groups is 1.5 and σ standard deviation 3.8.[7] The total required sample size is 202. Convenient sampling was the sampling strategy used to achieve the sample size.

The data collection was done using a case study form that consisted of demographic details and clinical details. The data regarding the awareness oflaboratory investigations was collected using a self-administered structured questionnaire. Table 1 shows the various study variables and their measurement/assessment methods.

The questionnaire was designed using an extensive literature search, which consisted of three sections with 30 questions.There were 16 questions to assess the awareness of laboratory investigations. The response option was based on linkert scale.  The maximum score was 64, and the minimum is 0. Based on the scores, the participants were divided into two groups, namely Group I - poor awareness (who obtained a score of less than 32) and Group II – good awareness (who obtained a score of more than 32). The content validity was checked by two subject experts involved in diabetic care. Next, after translating into a local language, face validity was done with a small group of participants to evaluate the clarity and relevance. Based on the feedback obtained, the questions were revised, and a pilot study was conducted using 10 participants similar to the study population to assess the clarity and comprehension.

Also, laboratory data from routine investigations were collected and recorded. Glycemic control between the two groups was compared based on the laboratory data. Also, the prevalence of complications was compared between the groups

Statistical analysis

All the data was entered in the Microsoft Excel 2010 version and was analysed by the Statistical Package for Social Sciences for Windows. For continuous variables mean and standard deviation were calculated. Categorical variables were expressed as frequencies and percentages. To assess the association between categorical variables Chi-square test was used. The t-test or Mann-Whitney U test was used to compare means of continuous variables between two groups.

Ethical Considerations

This study includes minimal risk. The nature of the study was explained to the participants in a language that they understand. Only interested participants fulfilling the criteria were included in the study after taking formal informed consent. This study was conducted after obtaining approval from the Institutional Ethics Committee. All the information used for the study was kept confidential.

Results

A total of 205 patients with DM were included in the analysis. The mean awareness score of the study population was 35.25 ± 11.32 (maximum possible score: 64). Based on predefined cut-offs, 111 participants (54.1%) were classified as having good awareness (mean score: 38.25 ± 8.06) and 94 participants (45.9%) as having poor awareness (mean score: 33.03 ± 6.55); this difference was statistically significant (p < 0.05).

Table 1: Study variables and its Assessment methods

Category

Variables            

Measurement/Assessment Method

 

 

 

Independent

Awareness score

Self-administered questionnaire

 

Age, gender, education,             duration of diabetes

Case record form

Dependent

FBS, PPBS, HbA1c

Measured using an automated analyser (mention brand/model)

 

Lipid profile

Enzymatic method

 

Serum urea, creatinine

Kinetic UV method

 

Liver function (ALT, AST, bilirubin, etc.)

Standardised enzymatic methods

Clinical

BMI

Weight (kg)/Height² (m²)

 

BP

Digital sphygmomanometer, measured twice, averaged

 

Medication adherence         

Self-reported

Behavioral

Lifestyle, diet, exercise

Questionnaire section

 

Frequency of medical check-ups

Self-reported


Note : FBS- Fasting Blood Sugar, PPBS- Post Prandial Blood Sugar, HbA1c – Glycated Hemoglobin, ALT- Alanine Transaminase, AST- Aspartate Transaminase

Table 2 shows the baseline characteristics of the two groups. The mean age of the study population was 55.15 ± 11.6 years. Participants with good awareness were significantly younger than those with poor awareness (51.74 ± 8.76 years vs. 57.69 ± 12.13 years; p < 0.001). Although males had slightly higher mean awareness scores than females (36.82 ± 10.25 vs. 34.91 ± 9.84), this difference was not statistically significant (p = 0.214).Educational status showed a strong association with awareness levels (p < 0.001). Graduates formed the majority of the good awareness group (61.2%), whereas participants who had only completed schooling or had no formal education were predominantly represented in the poor awareness group. With respect to occupation majority of the participants were employed (75.6%). A higher proportion of employed participants demonstrated good awareness compared to unemployed participants, this difference did not reach statistical significance (p = 0.0612).Residence was significantly associated with awareness levels (p < 0.005). Urban residents were more likely to have good awareness, while rural residents constituted the majority of the poor awareness group.

Table 2 Socio-demographic characteristics of the Good Awareness and Low Awareness groups

Table 3 shows the comparison of the clinical and biochemical parameters between the good and low awareness groups. Participants with good awareness had a longer duration of diabetes compared to those with poor awareness (6.20 ± 6.63 years vs. 4.51 ± 3.25 years; p = 0.019). Treatment modality differed significantly between groups (p = 0.043). Lifestyle modification alone or oral hypoglycaemic agents were more commonly reported in the good awareness group (84/111, 75.6%), whereas insulin-based therapy or no treatment was more frequent among participants with poor awareness (26/94, 27.7%). A family history of diabetes was present in 89 of 111 participants (80.1%) in the good awareness group compared with 62 of 94 participants (65.9%) in the poor awareness group (p = 0.021).The frequency of clinic visits per year was significantly higher among participants with good awareness (mean 3.2 ± 4.6 visits) than among those with poor awareness (1.8 ± 2.1 visits; p = 0.007). Although a higher proportion of participants with good awareness reported having attended an educational or awareness programme (58/111, 52.2%) compared to the poor awareness group (38/94, 40.4%), this difference was not statistically significant (p = 0.090).

Table 3: Comparison of Clinical and Biochemical Parameters Between Good and Low Awareness Groups

There were no significant differences between the good and poor awareness groups with respect to body mass index (26.2 ± 5.7 kg/m² vs. 25.8 ± 6.3 kg/m²; p = 0.633) or systolic blood pressure (130.4 ± 5.1 mmHg vs. 129.6 ± 5.2 mmHg; p = 0.268). Diastolic blood pressure was significantly lower in the good awareness group (73.3 ± 1.3 mmHg) compared with the poor awareness group (69.5 ± 1.8 mmHg; p = 0.003).

With regard to glycaemic control, fasting blood sugar levels were significantly lower among participants with good awareness (158.7 ± 9.5 mg/dL; n = 111) than among those with poor awareness (162.2 ± 10.7 mg/dL; n = 94; p = 0.013). Similarly, mean HbA1c levels were significantly better in the good awareness group (6.9 ± 2.13%) compared to the poor awareness group (7.5 ± 2.08%; p = 0.043). Postprandial blood sugar levels were higher in the poor awareness group, but the difference was not statistically significant (243.6 ± 38.5 mg/dL vs. 247.1 ± 40.2 mg/dL; p = 0.281).

The prevalence of diabetes-related complications was numerically higher in the poor awareness group compared to the good awareness group, including dyslipidaemia (18/94 [19.1%] vs. 15/111 [13.5%]), nephropathy (6/94 [6.3%] vs. 5/111 [4.5%]), and liver disease (3/94 [3.1%] vs. 7/111 [6.3%]); however, these differences were not statistically significant (p = 0.374).

Table 4 Correlation analysis demonstrated a significant negative association between awareness scores and fasting blood sugar (r = −0.42, p = 0.001) as well as HbA1c levels (r = −0.39, p = 0.002). No significant correlation was observed between awareness scores and postprandial blood sugar (r = −0.08, p = 0.36) or overall prevalence of complications (r = −0.15, p = 0.512).

Table 4: Correlation Between Awareness Scores and Glycemic Control Parameters

Discussion

In this study, which was conducted among 205 diabetic patients to assess the level of awareness and its association with glycemic control, nearly 54.1% of the participants had good awareness, and 45.9% had poor awareness. This indicates that although the majority of the patients had awareness, a considerable number of patients lacked adequate awareness. In a study conducted by Deepa et al in India, among four geographical areas, the 58.4% urban residents showed a higher awareness.[5] A study done by Kumar et al in  South India showed 52% of diabetic patients had satisfactory awareness of their laboratory monitoring and its role in disease control.[7] Our study, being done in a semi-urban area, shows comparable results to the above study.

Age was identified as a significant factor in determining the awareness.  The Poor Awareness group had a significantly higher mean age (57.69 ± 12.13 years) compared to the Good Awareness group (51.74 ±8.76 years), p value < 0.05. This finding aligns with studies suggesting that older populations may face challenges in accessing, processing, and integrating new health information, potentially due to lower digital literacy.[8,9] Conversely, younger individuals may exhibit greater receptivity to modern educational interventions and information dissemination channels.

Importantly, Gender did not show a statistically significant association with awareness. This suggests that the awareness may not be gender based and depends mainly on socio-economic factors such as age, education, and area of residence. In the study done by Sanjay et al in Singapore, no significant differences between awareness of HbA1c and gender were noted.[10] However, in another study done by Gosadi et al in Saudi Arabia et al males showed a significantly higher awareness than females. [11] This difference in awareness could be the difference in opportunities like health care access, education and cultural norms.

The most pronounced associations were observed with different educational statuses. Awareness levels exhibited a clear correlation with higher educational qualification, reinforcing that formal education is a powerful determinant of an individual’s health literacy. Many studies across the world also showed similar findings.[12],[13]

Awareness levels were higher among employed participants compared to unemployed or homemakers, though the difference was not statistically significant. Employment may enhance exposure to health information, structured routines, and access to healthcare, contributing to better awareness.

Residence also proved to be a critical determinant of awareness (p-value < 0.005). The Good Awareness group was largely urban (58.5%), while the Poor Awareness group was overwhelmingly rural (70.2%). This geographical disparity points to inequalities in access to centralised health facilities, educational opportunities, and communication technology.[14]

The present study revealed that the duration of diabetes, treatment type, family history, and frequency of clinic visits were significantly associated with the level of awareness among diabetic patients. Participants with good awareness had a longer mean duration of diabetes (6.20 ± 6.63 years) compared to those with poor awareness (4.51 ± 3.25 years), suggesting that prolonged exposure to disease management improves understanding through repeated clinical visits and self-monitoring experiences. This finding is consistent with Kumar et al, who reported that patients with longer disease duration had better knowledge of the importance of regular investigations and follow-up.[7] Similarly, Sekher et al observed that awareness about laboratory tests and glycemic control improved with time since diagnosis.[15]

The study also found a significant association between treatment modality and awareness levels, with those following lifestyle modifications and oral medications showing higher awareness compared to those dependent on insulin. This may be attributed to better health literacy and proactive engagement in disease management among the former group. The presence of a family history of diabetes was also associated with higher awareness, as family experience often facilitates shared knowledge and early exposure to diabetes education, similar to observations by.[8]

Furthermore, participants with good awareness reported more frequent clinic visits per year, emphasising the role of regular medical supervision in reinforcing patient knowledge and compliance. However, no significant difference was observed regarding participation in formal awareness programs, indicating the need for more structured and patient-centred educational interventions to enhance their effectiveness.

Although a higher percentage of patients with good awareness had attended educational programmes, the difference was not statistically significant, possibly due to variations in the quality, frequency, or recall of such sessions. This suggests that while educational exposure may contribute to better understanding, the quality, frequency, or retention of such programs could vary, influencing their overall impact.[14]

Regarding glycemic parameters, there was a better control of fasting glucose levels and HbA1c levels amoung the good awareness group compared to the poor awareness group, which was statistically significant. This indicates people who have awareness may have better control of their glucose parameters, but their awareness is restricted only to the disease and its associated lab values pertaining to the treatment taken. The awareness about lifestyle modifications, other complications is poor in the good awareness group.

The slightly higher prevalence of complications among patients with poor awareness suggests that inadequate knowledge about routine investigations may result in late diagnosis of complications.  However, the lack of statistical significance indicates that other factors, such as duration of diabetes, treatment adherence, and comorbidities, might influence complication development. Similar findings have been reported in studies highlighting that awareness alone may not directly predict complication rates unless accompanied by behavioural changes and regular follow-up.[12] Longitudinal studies are needed to establish whether improving awareness can lead to a meaningful reduction in diabetes-related complications.

This study has found an association between the awareness level and glycemic control. A significant negative correlation is seen with fasting blood glucose and the HbA1c with awareness score.  Similar findings have been reported by some studies around the world, emphasising the role of diabetes education in metabolic outcomes. In the study done by Dash et al it was found that patients with high scores, which measure the awareness of testing and complications, had low blood sugar levels.[6] Jabeen et al also found a significant association between knowledge of HbA1c and glycemic control ( p value 0.001)[16]. The lack of association with PPBS may be due to certain dietary variations and post-meal factors influencing glucose levels, unlike HbA1c and FBS, which reflect the accurate glycemic status. However, FBS and HbA1c are more accurate parameters for glycemic index rather than PPBS. Similarly, there was a non-significant negative correlation between the awareness score and the prevalence of complications. The weak correlation suggests that factors other than awareness—such as genetic predisposition, duration of diabetes, and comorbidities—may play a greater role in complication development. [4]

This study has a few limitations. Being a cross-sectional study, it was able to capture the associations rather than the causation between awareness and glycemic control. Moreover, the study data was from a single centre. Though the sample size is moderate, its generalisability to the public is limited. Due to the semi-urban nature of the area, there could have been an intrinsic potential for selection bias. Many responders were not willing the respond, which itself led to the exclusion of people with low health literacy. The complications were poorly recorded. The study also did not account for socioeconomic status, which could also have influenced on the awareness.

Conclusions

The present study demonstrates that patients with higher awareness of routine laboratory investigations tend to have better glycemic control, as evidenced by lower fasting blood glucose and HbA1c levels. This highlights the importance of patient knowledge as a key component of effective diabetes management. However, nearly half of the participants exhibited poor awareness, reflecting a major gap in diabetes education and health literacy, especially in semi-urban populations.

These findings underscore the need for structured, patient-centred educational programs that go beyond information delivery to include behavioural reinforcement, periodic follow-up, and digital or community-based interventions. Healthcare providers should integrate diabetes education as a continuous process within clinical visits to enhance patient engagement and compliance.

Being cross-sectional, the study cannot infer causality. It was limited to a single centre in a semi-urban area, and possible recall bias, selection bias, and lack of socioeconomic data may have influenced the findings.Longitudinal, multicentric studies with larger and more diverse populations are recommended to establish causal relationships and assess the long-term impact of awareness programs on metabolic outcomes and complications. Incorporating socioeconomic and psychological variables could provide deeper insights into barriers to effective disease management.

Funding:

Nil




Conflicts of Interest:

Nil


References

[1].    Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, et al. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract 2019;157:107843. 
[2].    Kumar A, Gangwar R, Zargar AA, Kumar R, Sharma A. Prevalence of Diabetes in India: A Review of IDF Diabetes Atlas 10th Edition. Curr Diabetes Rev 2024;20(1):e130423215752. 
[3].    Mathur P, Leburu S, Kulothungan V. Prevalence, Awareness, Treatment and Control of Diabetes in India From the Countrywide National NCD Monitoring Survey. Front Public Health 2022;10:748157. 
[4].    Podder V, Srivastava V, Kumar S, Nagarathna R, Sivapuram MS, Kaur N, et al. Prevalence and Awareness of Stroke and Other Comorbidities Associated with Diabetes in Northwest India. JNRP 2020;11:467–73. 
[5].    Deepa M, Bhansali A, Anjana RM, Pradeepa R, Joshi SR, Joshi PP, et al. Knowledge and awareness of diabetes in urban and rural India: The Indian Council of Medical Research India Diabetes Study (Phase I): Indian Council of Medical Research India Diabetes 4. Indian J Endocrinol Metab 2014;18(3):379–85. 
[6].    Prakruti Dash, Rajlaxmi Tiwari, Saurav Nayak. Awareness About Routine Laboratory Investigations Amongst Type 2 Diabetes Mellitus Patients and its Impact on Their Disease Status. Clin Invest 2022;12(9):181–8. 
[7].    Kumar DL, Mittal R, Bhalla A, Kumar A, Madan H, Pandhi K, et al. Knowledge and Awareness About Diabetes Mellitus Among Urban and Rural Population Attending a Tertiary Care Hospital in Haryana. Cureus 2023;15(4):e38359. 
[8].    Nagar V, Prasad P, Mitra A, Kale S, Yadav K, Shukla M. Assessment of knowledge, attitude and practice about diabetes among diabetic patients of tertiary care centre in central India. Int J Community Med Public Health 2018;5(9):4065. 
[9].    Ghadge SC, Gholap MC, Mohite DVR, Choudhari SK. A Study to Assess the Knowledge, Attitude and Practice Regarding Blood Glucose Monitoring among Diabetic Patients Attending at Tertiary Care Hospital, Karad. 2019;(3). 
[10].    Sanjay S, Chin YC, Sun Y, Ong EL, Au Eong KG. Awareness of HbA1c and Its Relationship With Diabetic Retinopathy Among Adult Diabetic Patients Attending a Tertiary Ophthalmic Center. Diabetes Care 2013;36(1):e1–e1. 
[11].    Gosadi IM, Daghriri KA, Otayf AA, Nemri AA, Kaal AA, Qussadi AM, et al. Are patients affected by chronic non-communicable diseases aware of their own clinical and laboratory parameters? A cross-sectional study from the south of Saudi Arabia. Saudi J Biol Sci 2021;28(5):2951–5. 
[12].    Cravo M, Rosendo I, Santiago LM, Abreu J. Health Literacy and Complications in People With Type 2 Diabetes: An Exploratory Study. Cureus 2023;15(9):e46064. 
[13].    Kim GH, Park Y, Lim HS. The Association between Diabetes Education and Glucose Control in Diabetic Patients: Using the 2008 and 2013 Korea National Health and Nutrition Examination Survey. Clin Nutr Res 2020;9(2):81. 
[14].    Veerasetty NK, Venkatachalam J, Subbaiah M, Arikrishnan K, Soni B. Determinants of health literacy and its impact on glycemic control among women with gestational diabetes mellitus in a tertiary care hospital, Puducherry - A cross-sectional analytical study. J Educ Health Promot 2024;13:119. 
[15].    Sekher TV, Flood D, Green H, Hu P, Ali MK, Shete A, et al. Prevalence, awareness, treatment, and control of diabetes in India: a nationally representative survey of adults aged 45 years and older. The Lancet Global Health 2025;13(9):e1543–52. 
[16].    Jabeen I, Prince SMKZ, Rishad MM, Noor N, Khan TR, Hassan R, et al. Knowledge and use of HbA1c among patients with type 2 diabetes mellitus admitted in a tertiary hospital. J Medicine 2025;26(1):20–7. 
 


IJBMR -ISSN: 0976:6685. ©Copyright 2026 This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Published by BioMedSciDirect Publications